SCHEMBL26548130

SCHEMBL26548130

Nc1ccc(C2CCS(=O)(=O)C2)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 2/20 0.37
SLC18A3 Q16572 1/20 0.36
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
MAPK1 P28482 3/20 0.34
CYP19A1 P11511 2/20 0.33
IKBKB O14920 1/20 0.33
NAMPT P43490 1/20 0.32
GAA P10253 2/20 0.32
GALR1 P47211 1/20 0.31
KDM1A O60341 1/20 0.31
MAOB P27338 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
IKBKE Q14164 1/20 0.31
TBK1 Q9UHD2 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3086027 0.88 SLC18A3 (0.41) SMN1; SMN2KMT2ALMNAMAPTSLC18A3
Trifluoroacetic Acid SCHEMBL23727646 0.86 MAPK1 (0.38) SMN1; SMN2KMT2ALMNASLC18A3MAPK1
SCHEMBL26548097 0.84 CYP19A1 (0.37) KMT2ALMNAMAPTSLC18A3DDB1
SCHEMBL16680561 0.81 MAPK1 (0.38) SMN1; SMN2KMT2ALMNAMAPTMAPK1
SCHEMBL20408764 0.81 MAPT (0.44) SMN1; SMN2KMT2ALMNAMAPTSLC18A3
SCHEMBL960888 0.80 L3MBTL1 (0.45) SMN1; SMN2LMNAMAPTSLC18A3IKBKB
SCHEMBL25301696 0.79 HTR3A (0.38) SMN1; SMN2KMT2ALMNAMAPTIKBKB
SCHEMBL28945417 0.75 MAPT (0.41) SMN1; SMN2KMT2AMAPTIKBKBGAA
SCHEMBL30933201 0.74 MAPK1 (0.38) SMN1; SMN2KMT2ALMNAMAPTMAPK1
SCHEMBL24757849 0.74 MAPK1 (0.38) SMN1; SMN2KMT2ALMNAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 SMN1; SMN2 1161/4885KMT2A 1669/4885LMNA 2810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.